Industry News
Bacteria invest in evolutionary success
Researchers at Sydney and Exeter Universities have, for the first time, recreated and analysed the complex interplay between bacterial investment strategies and their outcomes. [ + ]
Why one person’s mutation kills when the same mutation in someone else is benign
Scientists have begun to understand how the rest of the genome interacts with mutations, explaining why not everyone with identical genetic mutations develops a disease. [ + ]
Rigaku and Emerald Bio announce strategic alliance in protein crystallography
Rigaku, a supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallisation reagent and consumable business, including Wizard screens, from protein science company Emerald Bio. [ + ]
Sea simulator to solve the ocean’s mysteries
Minister for Innovation, Industry, Science and Research Senator Kim Carr and Senator for Queensland Jan McLucas yesterday opened the National Sea Simulator (SeaSim) at the Australian Institute of Marine Science (AIMS) in Townsville. [ + ]
GTG raising up to $10.6m for BREVAGen expansion
Genetic Technologies (ASX:GTG) is conducting a capital raising worth up to $10.6m and will use the funds to expand its US market reach for breast cancer risk test BREVAGen. [ + ]
Supercomputer switched on
Ranked as one of the largest supercomputers in the world, Australia’s fastest supercomputer has been turned on. [ + ]
Dr Greg Roger appointed as Medical and Scientific Technologies Supplier Advocate
Medical technology industry expert Dr Greg Roger has been appointed by the federal government as the Supplier Advocate for the growing medical technologies market. [ + ]
Australian Synchrotron home to world’s widest X-ray beam
Innovation Minister Senator Kim Carr yesterday opened a new $25 million imaging and medical beamline (IMBL), which will offer high-resolution, phase-contrast X-ray imaging of biomedical samples and a wide range of engineering materials. [ + ]
Biotron completes recruitment for HIV/HCV trial
Biotron (ASX:BIT) has signed up the 12th and final subject for a phase II open-label trial of BIT225 in patients co-infected with - and receiving treatment for - HIV and HCV. [ + ]
New WHO centre in Sydney
A new WHO centre for chronic diseases has been established in Sydney. [ + ]
Recycling helium
An onsite helium recovery system will make helium use more sustainable and help this finite resource be retained. [ + ]
Gtech International to merge with Simavita Holdings
Gtech International Resources, subsidiary of Genetic Technologies, has moved to acquire Simavita Holdings. [ + ]
Higher incidence of cancer for those near benzene release sites
An increased risk of Non-Hodgkin’s lymphoma (NHL) has been observed in recent years among individuals with occupational exposure to benzene, a chemical carcinogen linked to blood cancers. A study released in the journal Cancer set out to determine the risk of NHL for those living near benzene release sites. [ + ]
Student volunteer program for AusBiotech 2013 now open
Applications are now open for the annual AusBiotech Student Volunteer Program at AusBiotech’s national conference, this year to be held in Brisbane (30 October-1 November). [ + ]
Consegna picks manufacturer for nasal dilator
Consegna (ASX:CGP) has chosen ChinaMed as its global manufacturing partner for Turbine, a nasal dilator product bound for the Australian sporting goods market. [ + ]
